Neuroscience
Adenosine Triphosphate
8%
Alzheimer's Disease
26%
Amyloid Precursor Protein
8%
Astrocyte
41%
Astrogliosis
6%
Brain Ischemia
100%
Brainstem
8%
Cell Cycle
6%
Cell Death
5%
Cell Signaling
8%
Central Nervous System
6%
Cerebellum
7%
Cerebral Ischemia-Reperfusion Injury
8%
Cerebrovascular Accident
44%
Cognitive Disorders
10%
Cognitive Function
8%
Diethylstilbestrol
34%
Electron Transport
6%
Endothelin 1
6%
Estrogen Receptor
33%
Female Rats
14%
Glaucoma
5%
Glutamic Acid
18%
Hippocampus
8%
Hydrogen Peroxide
6%
Hyperphosphorylation
7%
In Vitro
28%
In Vivo
20%
Ischemia
31%
Messenger RNA
7%
Metabolic Pathway
10%
Methylene Blue
22%
Microglia
8%
Middle Cerebral Artery
40%
Mitochondrial Function
7%
Mitochondrion
24%
Neuroblastoma
6%
Neurodegeneration
12%
Neurodegenerative Disorder
11%
Neuronal Cell Death
6%
Neuroprotection
24%
Neuroprotective Agent
45%
Oxidative Stress
14%
Reactive Oxygen Species
5%
Reperfusion Injury
6%
Retinal Ganglion Cell
8%
Staining Technique
10%
T Cell
8%
Tauopathy
7%
Vascular Dementia
6%
Keyphrases
17-estradiol
27%
Alzheimer's Disease
18%
Amyloid Precursor Protein
8%
Apoptosis
9%
Aquaporin-4 (AQP4)
8%
Astrocytes
38%
Brain Injury
7%
Brainstem Glioma
8%
Cerebral Blood Flow
8%
Cerebral Ischemia
20%
Cerebral Ischemia-reperfusion Injury
8%
Cognitive Function
7%
Estradiol
8%
Estrogen
65%
Estrogen Receptor
28%
Experimental Ischemic Stroke
14%
Female Rats
14%
Focal Cerebral Ischemia
14%
Focal Ischemia
7%
Glioblastoma
7%
Glioma
12%
Glutamate
19%
HT22 Cells
7%
Hydrogen Peroxide
7%
Interleukin-10
7%
Ischemia
12%
Ischemia-reperfusion Injury
11%
Ischemic Damage
7%
Ischemic Stroke
50%
Matrix metalloproteinase-2 (MMP-2)
7%
Metformin
11%
Methylene Blue
28%
Microglia
7%
Mitochondria
22%
Neurodegeneration
8%
Neurodegenerative Diseases
9%
Neurofibrillary Tangles
7%
Neuroprotection
26%
Neuroprotective
9%
Neuroprotective Effect
29%
Overexpression
10%
Oxidative Stress
11%
Protective Effect
12%
Rat Model
9%
Recombinant Tissue Plasminogen Activator (rt-PA)
7%
Reperfusion
12%
T Cells
9%
Therapeutic Window
6%
Transient Cerebral Ischemia
19%
Transient Middle Cerebral Artery Occlusion (tMCAO)
31%